Background: Although patient-controlled analgesia (PCA) is an effective pain control
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INTRODUCTION
Patient-controlled analgesia (PCA, which may also signify nurse-or parent-controlled delivery) has been shown to be successful in managing pain in pediatric patients suffering from cancer [1] [2] [3] [4] , vaso-occlusive crises in sickle cell anemia, major burns, and postoperative recovery. 2, 5, 6 Unlike other methods of opioid administration, PCA allows for rapid patient-specific titration of doses to manage acute variations in pain levels. 2, 4, 7 Children prefer PCA to other methods of analgesia due to the elimination of unnecessary waiting time for relief and their enhanced control over pain. 3, 7 A general consensus also appears to exist in the literature that PCA is safe for use in pediatric patients. Even though children treated by PCA may receive higher daily opioid doses than those managed by other methods 8, 9 , several studies have demonstrated the incidence of serious side effects such as respiratory depression and neurologic complications to be low, ranging from 0-1.5% 3, 10, 11, 12 , and to be comparable to other routes of opioid administration. 5, 7, 13 Less serious side effects, such as pruritus and vomiting, are more common but comparable to the rates of side effects in children receiving a continuous opioid infusion, occurring in 39-67% of children using PCA. 3, 9, 14, 15 Due likely in part to these advantages of PCA, 96% of institutions surveyed in one study, including both children's and general hospitals, reported that PCA was available to all pediatric patients who needed it and who qualified based on age, mental status, and physical ability. 16 But there is a paucity of data on actual PCA utilization. Studies of children experiencing acute pain episodes from sickle cell anemia indicate that within M A N U S C R I P T
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6 this select population, PCA is used as the method of analgesia in only 50-75% of cases. 8, 17 PCA safety data are also lacking. Although generally considered to be safe, one study of children after scoliosis surgery reported 7% respiratory depression 14 , and another study documented clinically significant events, such as bradypnea, hypoxemia, and over-sedation, in up to 24% of pediatric patients receiving PCA. 12 Several case reports have suggested that concurrent use of sedatives may be associated with higher risk of respiratory depression 16, 18, 19 , but no comprehensive study of this relationship appears in the literature. Additionally, previous studies have been limited by small sample sizes 3, 9, 12 and single institution analysis. 10 Randomized clinical trials have been conducted comparing PCA versus conventional analgesia administration 20, 21 , but they were limited to patients with sickle cell disease, and encountered a substantial number of challenges during trial implementation.
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The present study aims to address gaps in knowledge regarding PCA use in hospitalized children. To do so, we studied exposure of patients receiving morphine (the most commonly used opioid) to delivery via the IV route exclusively or via a PCAdevice, acknowledging that PCA is a technique that requires more than just a PCA device. Specifically, we examined variation across hospitals in the use of these delivery methods, and evaluated whether PCA-device use was associated with increased risk of a particularly analgesia-related adverse event -severe respiratory depressioncompared to conventional IV analgesia in a large number of pediatric patients from multiple hospitals using the Pediatric Health Information System (PHIS) database. Our approach of detecting severe respiratory depression was indirect, as the data do not
contain physiologic measures of respiratory function; instead, we used the occurrence of cardiopulmonary resuscitation or receipt of mechanical ventilation (both of which are recorded in the data) as markers of this severe adverse event.
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METHODS
Human Subject Protections
This study was not deemed by the IRB of the Children's Hospital Of Philadelphia to constitute human subjects research.
Data Source
We used PHIS, which comprises administrative discharge data from 42 children's hospitals for major metropolitan areas across the United States, and is maintained by The Children's Hospital Association (CHA, Kansas City, KS). Our study included all records from 2007-2011 for hospitalized children between ages 5 and 21 who were exposed to opioids. We excluded patients younger than five years old because their
PCAs were more likely to be performed by proxies. PHIS data contains clinically detailed information, for every hospitalization, on each day of the hospital stay, including patient demographic characteristics and primary and secondary diagnoses and all procedures and pharmacy activity, including International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for each procedure and Clinical Transaction Classification (CTC) codes for each generic drug.
Analysis Strategy
We first sought to examine if there was considerable variation across hospitals in the PCA device delivery of morphine to hospitalized pediatric patients using multivariable fixed-effects logistic regression to get the predicted probability of morphine exposure for M A N U S C R I P T
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9 each hospital, after adjusting for patients' demographic and clinical characteristics.
Results are presented graphically.
Secondly, we performed comparative safety analyses to examine whether PCA usage was associated with increased risk of cardiopulmonary resuscitation (CPR) or mechanical ventilation (MV), which are proxy variables for respiratory depression. We focused on receipt of morphine via PCA, as morphine is one of the most commonly administered opioids for pain management. We used a propensity score matching approach and report relative and absolute measures of effect.
Description of study variables
We identified both CPR and MV by ICD-9-CM codes and CTC codes. We identified surgical procedures by both ICD-9-CM and Patient Refined Diagnosis Related Groups (APR-DRG) codes. We defined Complex Chronic Conditions (CCC) using our classification scheme based on ICD-9-CM codes. 20 We identified all exposures to opioids by generic drug names and the corresponding route of administration. We computed the total number of specific opioids used on each hospital day. Patients' demographic and clinical characteristics (listed in Tables 1-2) , except for patient length of stay and procedures, were used as covariates in analyses.
Analysis of hospital variation
To examine the distribution of morphine-specific PCA usage across hospitals, we estimated a fixed-effects logistic regression model to get the predicted probability of morphine PCA exposure for each hospital after adjusting for patient clinical and 
Construction of propensity scores
To assess the safety of PCA exposure, we used propensity score matching to compare PCA and IV-only groups. Propensity scores were constructed to identify morphine-IV only patients who are similar to those with morphine PCA (who often also received IV morphine) except for their PCA exposure. We estimated propensity scores by using multivariable logistic regression to predict PCA exposure on the first day of eligibility in each patient's hospital stay using relevant demographic and clinical patient characteristics. We assumed a linear relationship between each continuous predictor and the log-odds of PCA exposure.
Since the route of administration of a drug occurs at the patient level but is influenced by hospital factors, both the propensity score estimation and matching were conducted within hospital. Propensity scores were constructed within hospital, age strata (5-9, 10-14, 15-17, and 18-21), surgery strata, and day of hospitalization.
Analytic sample
For patients with more than one hospitalization in the study period, we randomly chose 
Missing data imputation
Logistic regression for a monotone missing pattern for binary variables was used to impute missing values for baseline demographic and clinical characteristics using 10
imputations. In order to avoid any incompatibility between propensity score estimation and multiple imputation, we created propensity scores for each imputed dataset and then used the average of each person's propensity scores 22, 23 .
Matching
We conducted 1:1 matching without replacement to further control for any imbalances due to observed covariates. The analysis used exact matching and nearest neighbor M A N U S C R I P T
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12 matching within propensity score calipers. Nearest neighbor matching within propensity score calipers was used to identify a control member "closest" to each patient administered PCA, preferentially within calipers of 0.25 standard deviations of the logit of the propensity score using the SAS macro gmatch. 24 Patients were also exactly matched on a receipt of other opioids that day, age, matching day, and hospital.
Balance diagnostics
In order to evaluate if each characteristic was balanced across the PCA and IV groups in each matched cohort, we computed standardized differences, which are not influenced by sample size, as well as the ratio of the variance of the demographic characteristic in each treatment group.
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Outcome variables
We examined if patients experienced CPR or MV, as separate dichotomous outcomes, on the baseline day (first day patients receive morphine via PCA or IV only); day 1) and in a two-day follow-up period (days 2 and/or 3). When examining the effect of baseline PCA on the occurrence of an outcome in the follow-up period, we excluded patients who experienced the outcome on day 1 or IV-only patients who received PCA after the baseline day. Because the PHIS data for CPR from 8 hospitals was not considered reliable, data from these hospitals were not included in the CPR outcome models.
Outcome models
We used multivariable logistic regression to model CPR or MV occurrence as a function of PCA or IV-only exposure in the matched sample with a robust variance estimator to M A N U S C R I P T
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13 account for clustering within hospital using the best fitting working correlation structure.
Any baseline covariate that had a residual imbalance in the matched cohort or was associated with the outcome was included as covariate in the regression. Results were presented as odds ratios (and 95% confidence intervals).
Since only a very small percentage of the sample died during their hospitalization, we did not adjust the estimates in the outcome models for the differential risk of survival.
For the outcome models, we present both relative and absolute measures to evaluate PCA safety. In addition to odds ratios, we calculated the marginal probability of each outcome occurring given all of the subjects had PCA exposure or IV-only exposure, and the 95% confidence intervals for these probabilities were estimated using 1000 parametric bootstrapped samples. The difference between these two marginal probabilities is the absolute reduction in the probability of the outcome occurring due to PCA exposure.
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Statistical Software
All data management and statistical analyses were conducted using SAS v9.3 (SAS Institute Inc., Cary NC). We used two-sided hypothesis tests and an alpha set to 0.05.
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RESULTS
Hospital Variation
Among 1,775,427 hospitalizations from the 42 children's hospitals, morphine PCA usage varied substantially across hospitals (Figure 1) . The marginal probability of morphine PCA usage ranged from less than 0.27 to 0.96 across the 42 hospitals.
Balance of Baseline Characteristics
We identified 45,445 non-surgical patients and 63,528 surgical patients who were eligible for propensity score analyses. Baseline demographic and clinical characteristics on the day of morphine exposure ( Table 1 ) reveal significant imbalances in the baseline characteristics across the two morphine groups.
After propensity score matching, the matched cohorts had comparable exposure groups in terms of demographics and clinical characteristics ( Table 2 ). The standardized differences were small (< 0.1) and the ratio of the variances were close to 1 for most covariates, indicating that there were few meaningful imbalances between the two groups on these observed characteristics. The number of non-surgical patients with a hematological/immunological CCC was slightly imbalanced between the two groups, so this characteristic was adjusted for in the outcome models.
CPR outcome models M A N U S C R I P T Table 3 presents the estimated effect of morphine PCA on the odds and absolute probability of CPR using the surgical and non-surgical matched cohorts.
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Events The marginal probabilities of CPR occurrence in both cohorts were very small (< 0.011).
The absolute reduction in the probability of same day CPR due to PCA exposure was less than a 0.5% reduction in both cohorts.
Events on Days 2 or 3 of Starting Opioid Exposure
Since there were fewer than 5 CPR events after baseline in both the non-surgical and surgical matched cohorts, the estimated odds ratios were not significant due to lack of power. Exposure to PCA was associated with increased odds of CPR occurrence in both cohorts, but not to a significant degree (surgical cohort, OR 1.81, 95% CI: 0.17, 19.82; non-surgical cohort, OR=0.99, 95% CI: 0.97, 1.01). The difference in the absolute probabilities for CPR occurrence attributable to PCA exposure was <0.1% in the surgical and <0.01% non-surgical cohorts, and also non-significant.
MV outcome models M A N U S C R I P T
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The results from the corresponding analyses for the MV outcome models using the surgical and non-surgical matched cohorts are presented in Table 4 .
Events on Day 1 of Starting Opioid Exposure MV occurred in less than 1% of the non-surgical cohort (37 events) and in close to 3%
of the surgical cohort (656 events) on day 1. In the non-surgical cohort, PCA exposure was associated with greater odds of MV but not to a significant degree (OR 1.40; 95% CI: 0.79, 2.49) and the difference in marginal probabilities of MV occurrence due to PCA exposure was very small in magnitude (<0.15%).
In the surgical cohort, PCA exposure was associated with lower odds of MV on the same day as exposure (OR 0.86; 95% CI: 0.71, 1.05). The marginal probabilities for MV occurrence in the surgical cohort were close to 0.03 for the IV exposure and PCA exposure, but the absolute reduction in the probability of a MV event occurring due to PCA exposure was still very small (~ 0.1%).
Events on Days 2 or 3 of Starting Opioid Exposure
In the follow-up period, less than 0.5% of the entire non-surgical and surgical cohorts had MV events; there were 29 and 61 MV events, respectively. The absolute reduction in the probability of MV occurrence due to PCA was also correspondingly small (<0.001).
When examining relative effect measures, PCA exposure was associated with a roughly 2-24% reduction in the odds of MV 1-2 days after starting opioid exposure, but none of these estimates were statistically significant (for non-surgical cohort, OR 0.98; 95% CI: 0.66, 1.47, and for surgical cohort, OR 0.74; 95% CI: 0.39, 1.42).
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DISCUSSION
Although a general consensus seems to exist in pediatrics that PCA usage is safe, there are no studies, to our knowledge, which compare the safety of PCA to conventional IV using a large sample from multiple children's hospitals and controlling for potential confounders. In this retrospective cohort, we found that patients who were administered morphine via PCA were not significantly more likely to experience a CPR or MV event using a propensity score matching approach that controlled for observed confounding due to patient and hospital-level factors.
Even though the absolute reductions in the probability of an adverse event occurring due to PCA are very small, the relative measures of effect show that morphine PCA exposure might have protective effects in both non-surgical and surgical patients.
Surgical patients administered morphine PCA had 2-24% lower odds of having a MV event up to 2 days after opioid exposure, though these estimates were not statistically significant. In both surgical and non-surgical patients, PCA exposure was associated with about 20-44% lower odds of same day CPR, with a slightly greater reduction in the odds of CPR in the surgical patients; however, when examining the same day morphine exposure and outcome results, it cannot be known with our data whether PCA exposure preceded CPR. Also, the CPR results based on the 34 PHIS hospitals with a reliable measure of CPR might not generalize to all 42 PHIS hospitals.
This study supports the belief that morphine administered via PCA might as safe in terms of receipt of CPR and MV compared to conventional IV analgesia among M A N U S C R I P T
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18 pediatric patients aged 5-21 years. Since this is the first large scale comparative effectiveness study of pediatric PCA safety, this belief would benefit from more comparative effectiveness studies to corroborate these findings. Additionally, the wide variation in the rate of use of PCA across hospitals suggest room for further practice guidelines and likely increased use of PCA in children's hospitals.
Our study has a few merits compared to previous studies. First, our study included multiple institutions and a large number of patients, with the sample of hospitals accounting for 85% of all freestanding children's hospitals within the US. 27 Secondly, the large sample size enabled a rigorous comparative safety analysis. We used a propensity score approach that adjusted for a comprehensive set of potential confounders to reduce the likelihood of "confounding by indication". While randomized clinical trials would minimize any potential confounding, they typically involve a much smaller sample size and a more selected population, whereas our study provided evidence that the overall effect of morphine via PCA in routine hospital care does not pose additional risk of CPR and MV compared to morphine via IV-only, and may even be safer. Thirdly, we chose the receipt of CPR and MV as our study outcomes, which are more severe adverse outcomes of morphine analgesia, and are less likely to be misclassified or undocumented in administrative databases compared to other less severe or more subjective adverse outcomes (such as milder respiratory depression, dysphoria, or nausea).
Our conclusions should, however, be interpreted with four limitations in mind. First, we had no detailed information about PCA administration in our database including the bolus dose, lockout intervals, dose limit, background infusion, and whether the PCA was M A N U S C R I P T
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closely monitored or not. Such parameters of PCA administration are important in reducing PCA associated adverse outcomes. While our study suggests that PCA is safe compared to conventional IV, further studies are needed to evaluate PCA safety using more parameters of PCA administration and to provide detailed practice guidelines on PCA administration for pediatric patients in hospitals.
Secondly, our study examined only CPR and MV as study outcomes, which are proxies for a more severe opioid-related adverse effect: over-sedation and respiratory depression. To provide a more comprehensive safety profile of PCA, other less severe adverse effects including oxygen desaturation, nausea, pruritus, constipation, urinary retention, and dysphoria should be assessed in future studies. Additionally, we examined only PCA administration of morphine, which is one of the most commonly administered opioids, and we were underpowered to perform the same rigorous comparative effectiveness research on other opioids that can also be administered via PCA.
Thirdly, propensity approaches work best when all relevant factors are included in the models. Some factors may have been missed or were not available using PHIS, such as the patient's pain level and preference for PCA. Instrumental variables or other approaches that control for unmeasured variables might be worth examining. We also did not examine PCA use by surgery type, while a meta-analysis suggested that PCA may have varying effectiveness depending on the extent and degree of invasiveness of the surgery after which it is administered.
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Fourth, we chose a relative short outcome window for our analyses and did not include outcomes that happened beyond the two-day outcome window after PCA initiation. This is because most morphine related respiratory depression occurred within 3 days of PCA initiation, and in fact the majority of CPR occurred on the same day as morphine exposure.
In summary, our comparative effectiveness study suggests that morphine administered via PCA is at least as safe, or maybe even safer, compared to conventional IV-only administration in terms of receiving CPR and/or MV in this pediatric patient cohort.
Further studies are needed to provide a more comprehensive safety profile of PCA, and to provide detailed PCA administration information (PCA parameters) to guide clinical practice. Given that PCA enhances patients' experience of self-control of pain, and PCA is as safe as the conventional IV-only analgesia, more pediatric patients should be provided with PCA. Hospital volume is the total number of patients at that hospital who were exposed to morphine during the study period. Hospital volume (Total number of patients)
